<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec25" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Effects on lipid peroxidation</div>
 <p id="Par58" xmlns="http://www.w3.org/1999/xhtml">TBARS level is widely used as a marker for free radical mediated lipid peroxidation injury. We determined TBARS levels in the liver and kidney tissues of the investigated animals and our results are shown in Fig. 
  <a rid="Fig1" ref-type="fig" href="#Fig1">1a, b</a>. The levels of TBARS were significantly increased in both liver and kidney tissues of CCl
  <sub>4</sub>-treated animals when compared to control untreated rats.
  <div id="Fig1" class="fig">
   <span class="label">Fig. 1</span>
   <div class="caption">
    <p>
     <span class="bold">a</span> Effects of CCl
     <sub>4</sub>, MpEO and their combinations MpEO/CCl
     <sub>4</sub> on hepatic TBARS of control (Con) and experimental rats. Con, control group; mod, CCl
     <sub>4</sub>-model group
     <sub>;</sub> SL/CCl
     <sub>4</sub>, silymarin 50 mg/kg + CCl
     <sub>4</sub>; MpEO/CCl
     <sub>4</sub> 5 mg/kg + CCl
     <sub>4</sub> group; MpEO/CCl
     <sub>4</sub> 15 mg/kg + CCl
     <sub>4</sub> group; MpEO/CCl
     <sub>4</sub> 40 mg/kg + CCl
     <sub>4</sub> group; MpEO 40 mg/kg group. Values are mean ± SEM for ten rats in each group. CCl
     <sub>4</sub>, MpEO, MpEO/CCl
     <sub>4</sub> treated groups vs control group; *
     <span class="italic">p</span> &lt; 0.05, **
     <span class="italic">p</span> &lt; 0.01, *** 
     <span class="italic">p</span> &lt; 0.001, CCl
     <sub>4</sub> group vs (MpEO/CCl
     <sub>4</sub>) group; #
     <span class="italic">p</span> &lt; 0.05, ##
     <span class="italic">p</span> &lt; 0.01, ###
     <span class="italic">p</span> &lt; 0.001. 
     <span class="bold">b</span>. Effects of CCl
     <sub>4</sub>, MpEO and their combinations 
     <span class="strike">(</span>MpEO/CCl
     <sub>4</sub>
     <span class="strike">)</span> on kidney TBARS of control (Con) and experimental rats. Con, control group; mod, CCl4-model group
     <sub>;</sub> SL/CCl
     <sub>4</sub>, silymarin 50 mg/kg + CCl
     <sub>4</sub>; MpEO/CCl
     <sub>4</sub> 5 mg/kg + CCl
     <sub>4</sub> group; MpEO/CCl
     <sub>4</sub> 15 mg/kg + CCl4 group; MpEO/CCl
     <sub>4</sub> 40 mg/kg + CCl4 group; MpEO 40 mg/kg. Values are mean ± SEM for ten rats in each group. CCl
     <sub>4</sub>, MpEO, MpEO/CCl
     <sub>4</sub> treated groups vs control group; *
     <span class="italic">p</span> &lt; 0.05, **
     <span class="italic">p</span> &lt; 0.01, *** 
     <span class="italic">p</span> &lt; 0.001, CCl
     <sub>4</sub> group vs (MpEO/CCl
     <sub>4</sub>) group; #
     <span class="italic">p</span> &lt; 0.05, ##
     <span class="italic">p</span> &lt; 0.01, ###
     <span class="italic">p</span> &lt; 0.001
    </p>
   </div>
   <div xlink:href="12944_2017_645_Fig1_HTML" id="MO1" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </div>
 </p>
 <p id="Par59" xmlns="http://www.w3.org/1999/xhtml">Pre-treatment with the MpEO at doses of 15 and 40 mg/kg BW significantly reduced levels of TBARS in liver and kidney tissues as compared to CCl
  <sub>4</sub> group. There was a dose effect; treatment with MpEO at 5 mg/kg BW did not induce any significant decrease in the levels of TBARS in liver and kidney as compared to CCl
  <sub>4</sub> group. When rats were treated with only MpEO (40 mg/kg BW), no significant differences in the TBARS values was observed compared to control rat. Pretreatment with silymarin (50 mg/kg) significantly decreased the elevated levels of TBARS in both liver and kidney compared to CCl
  <sub>4</sub> control. Moreover, the effect of silymarin (50 mg/kg) in attenuation of TBARS levels in liver and kidney was comparable with highest dose of MpEO (40 mg/kg).
 </p>
</sec>
